Physician
Pediatric Hematology & Oncology
Dr. Marcio H. Malogolowkin, MD
|
|
Give Review
Marcio Malogolowkin is an expert in the field of Pediatric Hematology & Oncology. He over the years received 1 awards: "Super Doctor". Marcio Malogolowkin is a published doctor as well. He has 59 publications published. The latest was: Risk factors for early infection of central venous catheters in pediatric patients.
Publications
- Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma.
- Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: A report from the Children's Oncology Group.
- The Teen Impact Experience: A Webcast Pilot Project for Teens With Cancer and Blood Diseases.
- Congenital abnormalities and hepatoblastoma: A report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB).
- Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy.
- Surveillance After Initial Surgery for Pediatric and Adolescent Girls With Stage I Ovarian Germ Cell Tumors: Report From the Children's Oncology Group.
- Outcomes for patients with congenital hepatoblastoma.
- Incidence and outcomes of patients with late recurrence of Wilms' tumor.
- Treatment of multiply relapsed wilms tumor with vincristine, irinotecan, temozolomide and bevacizumab.
- Towards an international pediatric Liver tumor consensus classification: proceedings of the Los Angeles COG Liver tumors symposium.
- Outcome of patients with stage II/favorable histology wilms tumor with and without local tumor spill: A report from the National Wilms Tumor Study Group.
- Parental tobacco and alcohol use and risk of hepatoblastoma in offspring: A report from the Children's Oncology Group.
- Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: A report of the children's o...
- A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors.
- Pleuropulmonary Blastoma: A Single-institution Experience.
- Treatment of hepatoblastoma: the North American cooperative group experience.
- Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma.
- Complete Surgical Resection Is Curative for Children With Hepatoblastoma With Pure Fetal Histology: A Report From the Children's Oncology Group.
- Critical review of controversial issues in the management of advanced pediatric Liver tumors.
- Gorham's disease and diffuse lymphangiomatosis in children and adolescents.
- Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group.
- Redefining the role of doxorubicin for the treatment of children with hepatoblastoma.
- Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma.
- Extracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience.
- Treatment of infantile choriocarcinoma of the Liver.
- Predictive value of staging Systems in hepatoblastoma.
- Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
- Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup study.
- Fibrolamellar hepatocellular carcinoma in children and adolescents.
- Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study.
- A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors.
- Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group.
- Mycotic aneurysm of the thoracic aorta due to Aspergillus terreus: case report and review.
- Presence of well-differentiated rhabdomyoblasts at the end of therapy for pelvic rhabdomyosarcoma: implications for the outcome.
- Feasibility and toxicity of chemoembolization for children with Liver tumors.
- Complications of Cancer therapy in children: a radiologist's guide.
- Risk factors for early infection of central venous catheters in pediatric patients.
- Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
- A prospective study of vancomycin pharmacokinetics and dosage requirements in pediatric Cancer patients.
- Rhabdomyosarcoma of childhood.
- Tracing expert thinking in clinical trial design.
- Immature teratomas: identification of patients at risk for malignant recurrence.
- Germ cell tumors in infancy and childhood: a 45-year experience.
- Results of treatment of malignant germ cell tumors in 93 children: a report from the Childrens Cancer Study Group.
- Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
- Post-transplant multiple myeloma in a pediatric renal transplant patient.
- Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children''s Oncology ...
- Predictors of outcome in children with Langerhans cell histiocytosis.
- Management of Wilms'' tumour: current practice and future goals.
- Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
- Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group.
- Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil.
- Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Stud...
- Establishment and characterization of a Cancer cell line derived from an aggressive childhood liver tumor.
- Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
- A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study.
- Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5.
- Treatment of relapsed Wilms tumors: lessons learned.
Schools
Universidade Federal De Rio De Janeiro
Children39s Hospital Of Los Angeles
Conditions Treated
- Acute Leukemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Cancer
- Liver Cancer
- View All
Doctors Specialties
- Hematology
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- Super Doctor
Education
-
Children's Hospital of Los Angeles -
Faculdade de Medicina da Universidade Federal do Rio de Janeiro
Hospital
-
Children's Hospital Los Angeles -
Children's Hospital of Wisconsin -
University of California, Davis Medical Center
Helpful Reviews
Similar Doctors
|
Christina M. Schulta, APNP |
|
Dr. Laura C. Michaelis, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leena Maramattom, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard L. Tower II, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Veronica H. Flood, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Cheryl A. Hillery, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Christopher N. Bredeson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah K. Dobrozsi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anna Vinitsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James D. Rizzo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Namrata M. Shah, MD |